HI
MRNA icon

Harbour Investments’s Moderna MRNA Stock Holding History

Harbour Investments’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$89.7K Sell
1,280
-169
-12% -$8.74K ﹤0.01% 2075
2026
Q1 		$73.6K Sell
1,449
-1,067
-42% -$49.8K ﹤0.01% 2126
2025
Q4 		$74.2K Sell
2,516
-522
-17% -$14.2K ﹤0.01% 1774
2025
Q3 		$78.5K Buy
3,038
+1,067
+54% +$29.8K ﹤0.01% 1680
2025
Q2 		$54.4K Buy
1,971
+957
+94% +$25.2K ﹤0.01% 1774
2025
Q1 		$28.7K Buy
1,014
+124
+14% +$4.4K ﹤0.01% 2031
2024
Q4 		$37K Buy
890
+16
+2% +$765 ﹤0.01% 1857
2024
Q3 		$58.4K Sell
874
-490
-36% -$45K ﹤0.01% 1582
2024
Q2 		$162K Sell
1,364
-35
-3% -$4.43K 0.01% 1028
2024
Q1 		$149K Buy
1,399
+13
+0.9% +$1.31K 0.01% 1034
2023
Q4 		$138K Sell
1,386
-273
-16% -$23K 0.01% 1006
2023
Q3 		$171K Sell
1,659
-153
-8% -$17.1K 0.01% 843
2023
Q2 		$220K Buy
1,812
+82
+5% +$10.9K 0.01% 763
2023
Q1 		$266K Buy
1,730
+37
+2% +$6.1K 0.01% 666
2022
Q4 		$304K Sell
1,693
-374
-18% -$61.2K 0.02% 590
2022
Q3 		$295K Hold
2,067
– – 0.02% 559
2022
Q2 		$295K Buy
+2,067
New +$295K 0.02% 559
2021
Q4 		$516K Sell
2,032
-6,677
-77% -$1.95M 0.03% 422
2021
Q3 		$3.35M Sell
8,709
-511
-6% -$188K 0.11% 180
2021
Q2 		$2.17M Sell
9,220
-1,666
-15% -$298K 0.07% 263
2021
Q1 		$1.43M Buy
+10,886
New +$1.58M 0.05% 318

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Harbour Investments's MRNA Position: Q2 2026 in Review

Harbour Investments reduced its Moderna (MRNA) stake by 12% in Q2 2026, selling an estimated $8.74K and leaving 1,280 shares worth $89.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2075.

Harbour Investments first reported a position in MRNA in Q1 2021 and has held it in 21 quarters since. The position peaked at $3.35M in Q3 2021. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Harbour Investments held 1,280 shares of Moderna worth $89.7K as of Q2 2026.
  • Harbour Investments sold 169 Moderna shares in Q2 2026, an estimated $8.74K.
  • Moderna made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #2075 holding.
  • Harbour Investments first reported a position in Moderna in Q1 2021 and has held it in 21 quarters since.
  • Harbour Investments's Moderna position peaked at $3.35M in Q3 2021.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.